See every side of every news story
Published loading...Updated

Opus Genetics Announces Financial Results for Full Year 2024

Summary by Eyewire+
Opus Genetics announced financial results for the full year ended December 31, 2024, and provided a corporate update. “2024 marked a year of significant progress and change for the Company,” said George Magrath, MD, CEO. “We began the year with an uncertain future, with a lead asset that had failed to meet its primary endpoints in Phase 2 and another asset that had been fully out-licensed for commercialization. Given this portfolio, we took deci…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Eyewire+ broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.